AKT1 and cancer: In the work presented here, we provide evidence that the increase in mTORC2 (Akt phosphorylation at S473) in response to exogenously supplied OA and de novo synthesis of PA lead to the phosphorylation of ACLY in KRas-driven cancer cells.